title: The short-term effect of hyperoncotic albumin, given alone or with furosemide, on oxygenation in sepsis-induced acute respiratory distress syndrome.
abstract: Two prospective non-randomised interventional case series were conducted consecutively at a single university hospital mixed intensive care unit, in patients with severe sepsis and acute respiratory distress syndrome. The first series describes the administration of 200 ml of 20% human albumin solution over 120 s in 13 patients, examining the hypothesis that raising plasma albumin should improve oxygenation. The second series describes the effect of administering 30 mg of furosemide intravenously along with the albumin in 15 patients, exploring whether this would produce more sustained improvement in oxygenation than albumin only. Oxygenation and haemodynamic parameters were measured for 4 h, during the period of peak oncotic effect. Hyperoncotic albumin given alone or with furosemide produced only transient improvement in oxygenation and haemodynamics, which was statistically significant only in the patients given albumin alone. Although the plasma albumin remained significantly elevated at 4 h in both series, no sustained improvement in oxygenation was seen.
authors.affiliation: Department of Anaesthesia, Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK. albumin@martinkuper.com
authors.forename: M
authors.initials: M
authors.lastname: Kuper
authors.forename: M P
authors.initials: MP
authors.lastname: Gunning
authors.forename: S
authors.initials: S
authors.lastname: Halder
authors.forename: N
authors.initials: N
authors.lastname: Soni
mesh_terms: D000328:Adult; D000368:Aged; D000418:Albumins / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004232:Diuretics / Q000627:therapeutic use; D005260:Female; D005665:Furosemide / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010100:Oxygen / Q000097:blood; D010313:Partial Pressure; D010952:Plasma Substitutes / Q000627:therapeutic use*; D011446:Prospective Studies; D012128:Respiratory Distress Syndrome / Q000097:blood / Q000209:etiology / Q000628:therapy*; D018805:Sepsis / Q000150:complications*; D012709:Serum Albumin / Q000378:metabolism; D016896:Treatment Outcome
chemical_list: D000418:Albumins; D004232:Diuretics; D010952:Plasma Substitutes; D012709:Serum Albumin; C028426:hyperoncotic albumin; D005665:Furosemide; D010100:Oxygen